Living donor liver transplantation for patients with hepatocellular carcinoma
about
Selection Criteria and Current Issues in Liver Transplantation for Hepatocellular CarcinomaSelection of patients with hepatocellular carcinoma for liver transplantation: Past and futureSurgical approach for hepatitis C virus-related hepatocellular carcinomaSurgery and Hepatocellular CarcinomaLiver transplantation for hepatocellular carcinoma from living-donor vs. deceased donorLiver transplantation for advanced hepatocellular carcinomaHepatocellular carcinoma: A comprehensive reviewPhase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-FluorouracilCurrent management of patients with hepatocellular carcinoma.A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatmentIndications for living donor liver transplantation in patients with hepatocellular carcinoma.Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.Clinical Impacts of Donor Types of Living vs. Deceased Donors: Predictors of One-Year Mortality in Patients with Liver Transplantation.Use of a Right Lateral Sector Graft in Living Donor Liver Transplantation Is Feasible, but Special Caution Is Needed With Respect to Liver Anatomy.The role of liver transplantation or resection for patients with early hepatocellular carcinoma.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Twenty years of Milan criteria: how far do we go.Liver transplantation from living donors with Gilbert's syndrome is a safe procedure for both donors and recipients.Current topics in the surgical treatments for hepatocellular carcinoma.Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong KongA Comparison of Iron Oxide Particles and Silica Particles for Tracking Organ Recellularization
P2860
Q26744102-10330BEA-7A22-48A7-929A-3BB06C0F03D8Q26771246-1BC87FB6-2300-422C-8CCF-819DE42C4448Q26824046-D41F3878-4368-43F1-BE2E-4D11F825CFB4Q28072274-64DFF5FB-3C4C-4511-920F-C65F1EC26746Q28073940-D6DA514B-4C3E-40FB-B301-3CABF1EAAB45Q28074653-BB0EC57C-9D98-42EE-936D-89AEAF538911Q28087638-6416F59C-BBC5-4CDA-ACCA-D6E615545C4AQ33428936-049FD8D0-F7CF-49CE-9FD6-0C9B92C5D531Q35895363-C6D9ECE0-ECC6-4B8F-8ED6-B5C30B0C981FQ37215092-D52BC958-1C4C-46E7-A83D-65A624EA6484Q37360166-0BF5A5E4-1341-46EA-84B6-BB925A9EB165Q37360183-9FC2D23A-8360-4612-9436-D13F1D1A7A9AQ39067623-79942011-2466-4AAD-B55D-64260D7D600EQ40152475-78E4DE7A-0491-44B2-BC0D-BF93255A5BCDQ40280101-2E90FC03-C439-4B5B-9243-130ACC92AF95Q41194963-C4B8C4DE-9356-47E1-9F9C-1BA5FC1BBB1CQ41962614-ABFCFB7C-81C0-4C20-8D48-052F413F5C07Q42333007-03F8006E-F76B-4814-9CDF-A4214C77BDBDQ50995608-F067E3FF-ED2C-43E8-8848-8DB563DDED5EQ55322423-2E89F580-054D-4543-A344-BF73BA79A3FCQ57066918-E91B8D4F-BB01-412C-A293-DFDA161FCA7AQ57182077-B794723E-84F3-40E5-BE5B-0119CE7E3FF3
P2860
Living donor liver transplantation for patients with hepatocellular carcinoma
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Living donor liver transplantation for patients with hepatocellular carcinoma
@en
type
label
Living donor liver transplantation for patients with hepatocellular carcinoma
@en
prefLabel
Living donor liver transplantation for patients with hepatocellular carcinoma
@en
P2860
P356
P1433
P1476
Living donor liver transplantation for patients with hepatocellular carcinoma
@en
P2093
Nobuhisa Akamatsu
P2860
P304
P356
10.1159/000343866
P577
2014-05-01T00:00:00Z